Healthcare of Ontario Pension Plan Trust Fund raised its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 198.6% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 9,229,000 shares of the exchange traded fund’s stock after purchasing an additional 6,138,000 shares during the quarter. SPDR S&P Biotech ETF accounts for 2.2% of Healthcare of Ontario Pension Plan Trust Fund’s portfolio, making the stock its 8th biggest position. Healthcare of Ontario Pension Plan Trust Fund owned 12.11% of SPDR S&P Biotech ETF worth $911,825,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also recently made changes to their positions in XBI. Tidemark LLC lifted its holdings in SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after buying an additional 199 shares during the period. Quintet Private Bank Europe S.A. purchased a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at approximately $40,000. ORG Partners LLC purchased a new stake in SPDR S&P Biotech ETF in the second quarter worth $40,000. ORG Wealth Partners LLC purchased a new stake in SPDR S&P Biotech ETF in the third quarter worth $44,000. Finally, Howe & Rusling Inc. bought a new stake in SPDR S&P Biotech ETF in the third quarter valued at $49,000.
SPDR S&P Biotech ETF Stock Performance
SPDR S&P Biotech ETF stock opened at $98.80 on Wednesday. SPDR S&P Biotech ETF has a fifty-two week low of $71.99 and a fifty-two week high of $105.47. The stock has a market cap of $7.53 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The stock’s 50 day simple moving average is $98.37 and its two-hundred day simple moving average is $96.38.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
See Also
- Five stocks we like better than SPDR S&P Biotech ETF
- How to Effectively Use the MarketBeat Ratings Screener
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Utilities Stocks Explained – How and Why to Invest in Utilities
- 2 Generic Drug Stocks Ready to Surge in 2025
- How to Invest in Blue Chip Stocks
- 3 Small-Cap Stocks That Are Ready to Rocket Higher
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.